IR @ Nirma University
Keeping in tune the global developments we are creating an institutional repository using DSpace Software (Digital Library Software). We are archiving institutional knowledge like, faculty papers, theses, and dissertations in PDF format at DSpace. Students can access this digital information anywhere in the campus.
Please use this identifier to cite or link to this item:
http://10.1.7.192:80/jspui/handle/123456789/8469Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Pandey, Anurag | - |
| dc.date.accessioned | 2019-07-12T08:40:44Z | - |
| dc.date.available | 2019-07-12T08:40:44Z | - |
| dc.date.issued | 2019-05 | - |
| dc.identifier.uri | http://10.1.7.192:80/jspui/handle/123456789/8469 | - |
| dc.description.abstract | Future Market Insights forecasts the global oral solid dosage pharmaceutical formulation market to raise from US$ 493.2 Billion in 2017 to US$ 926.3 Billion by 2027 end. This signifies a value CAGR of 6.5% over the forecast period/duration 2017– 2027. Several vital factors drive this evolution. So, these present factors are in detail in this introduction report. A snapshot is captured below for ease understanding | en_US |
| dc.publisher | Institute of Pharmacy, Nirma University, A'bad | en_US |
| dc.relation.ispartofseries | PDR00541;17MPH101 | - |
| dc.subject | PDR00541 | en_US |
| dc.subject | Pharmaceutics | en_US |
| dc.subject | Dissertation Report | en_US |
| dc.title | Polymorphic Stabilization and Performance Evaluation of an urinary tract anti Infective drug by addition of a crystal growth inhibitor | en_US |
| dc.type | Dissertation | en_US |
| Appears in Collections: | M.Pharm. Research Reports, Pharmaceutical Analysis | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| PDR00541.pdf | 5.51 MB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.